Shandong Sinobioway Biomedicine Balance Sheet Health
Financial Health criteria checks 6/6
Shandong Sinobioway Biomedicine has a total shareholder equity of CN¥2.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.3B and CN¥90.9M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥428.85m |
| Equity | CN¥2.20b |
| Total liabilities | CN¥90.89m |
| Total assets | CN¥2.30b |
Recent financial health updates
No updates
Recent updates
There's Reason For Concern Over Shandong Sinobioway Biomedicine Co., Ltd.'s (SZSE:002581) Massive 43% Price Jump
Oct 08
Shandong Sinobioway Biomedicine Co., Ltd.'s (SZSE:002581) Business Is Yet to Catch Up With Its Share Price
Aug 19Shandong Sinobioway Biomedicine Co., Ltd.'s (SZSE:002581) 26% Price Boost Is Out Of Tune With Revenues
Mar 06Financial Position Analysis
Short Term Liabilities: 002581's short term assets (CN¥721.9M) exceed its short term liabilities (CN¥64.6M).
Long Term Liabilities: 002581's short term assets (CN¥721.9M) exceed its long term liabilities (CN¥26.3M).
Debt to Equity History and Analysis
Debt Level: 002581 is debt free.
Reducing Debt: 002581 has no debt compared to 5 years ago when its debt to equity ratio was 28.6%.
Debt Coverage: 002581 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 002581 has no debt, therefore coverage of interest payments is not a concern.